Newer antiepileptic drugs
. In 1996 the first case of visual field defect, a serious irreversible loss of peripheral vision, was reported in association with VGB, followed by increased recognition of the frequency of this unique adverse effect in over 60% of patients (5) . As the defects cannot be tested in children, VGB, initially marketed for treating partial epilepsy, was virtually abandoned except for special situations.
The recommended starting dose is 40 mg/kg per day, which can be increased to 50-100 mg/kg per day as required. In West syndrome, dosages of more than 100 mg/kg per day have been used (4) . 
Oxcarbazepine
Oxcarbazepine (OXC), a saturated analogue of CBZ that is devoid of the ability to be transformed to the 10, 11-epoxide, has a pharmacologic spectrum and potency similar to that of CBZ, but a lower incidence of adverse effects such as rash and hypersensitivity reactions (19) . OXC has a higher incidence of laboratory abnormalities, especially hyponatraemia, but this finding infrequently leads to complications (20) . 
Ketogenic diet
The ketogenic diet (KD) is high fat, adequate protein and low carbohydrate diet, and has been shown to be an effective alternative treatment for children with medically intractable epilepsy (28).
Historically, it was originally developed in the 1920s, but was not used until 1994 
Epilepsy Surgery
When epilepsy is intractable to medical treatment, surgical resection of the tissue responsible for the epilepsy should be con- 
VNS (vagal nerve stimulation)
Electrical stimulation of the vagus nerve (VNS) is a neuromodulatory treatment 
Other advanced therapy
There are other experimental trials for 
